In a discovery that researchers hope could have similar effects in humans, a drug has been found to increase the lifespan of laboratory animals by almost 25%.   

Another obesity drug could be on its way to the market after Roche announces positive results for its drug in a phase I trial.

Type 2 diabetes has replaced COVID-19 on the list of the world’s most studied diseases this year, according to a study by Phesi.

A breakthrough fertility drug that could improve the chances of IVF success has announced positive Phase 2 results.

Explore the top tech stories that have shaped pharma in recent months as we explore implants to AI models, with a particular focus on antimicrobial resistance.

Discover June’s top pharma news in our monthly round-up. From the latest market predictions to new vaccine development initiatives, there’s plenty to discover.

A new study finds that patients with type 2 diabetes taking GLP-1 treatments have a reduced chance of developing obesity-related cancers.

Siemens Healthineers has received CE Mark approval for its test for the management of relapsing multiple sclerosis, allowing it to be launched in Europe.